Tong Ren Tang Technologies Co. Ltd. (TGRNF)
USD 0.69
(0.0%)
USD 0.69
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.5 Billion CNY | 8.19% |
| 2022 | 12.48 Billion CNY | 7.68% |
| 2021 | 11.59 Billion CNY | 5.97% |
| 2020 | 10.94 Billion CNY | 4.5% |
| 2019 | 10.46 Billion CNY | 7.17% |
| 2018 | 9.76 Billion CNY | 10.07% |
| 2017 | 8.87 Billion CNY | 8.45% |
| 2016 | 8.18 Billion CNY | 32.38% |
| 2015 | 6.18 Billion CNY | 11.75% |
| 2014 | 5.53 Billion CNY | 7.46% |
| 2013 | 5.14 Billion CNY | 62.46% |
| 2012 | 3.16 Billion CNY | 12.46% |
| 2011 | 2.81 Billion CNY | 29.55% |
| 2010 | 2.17 Billion CNY | 15.15% |
| 2009 | 1.88 Billion CNY | 5.23% |
| 2008 | 1.79 Billion CNY | 2.72% |
| 2007 | 1.74 Billion CNY | 16.5% |
| 2006 | 1.5 Billion CNY | 3.45% |
| 2005 | 1.45 Billion CNY | 15.42% |
| 2004 | 1.25 Billion CNY | 39.82% |
| 2003 | 898.51 Million CNY | 13.4% |
| 2002 | 792.32 Million CNY | 28.24% |
| 2001 | 617.86 Million CNY | 19.37% |
| 2000 | 517.6 Million CNY | 131.66% |
| 1999 | 223.42 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 14.28 Billion CNY | 5.78% |
| 2024 Q2 | 14.28 Billion CNY | 0.0% |
| 2023 Q2 | 13.08 Billion CNY | 0.0% |
| 2023 FY | 13.5 Billion CNY | 8.19% |
| 2023 Q1 | 13.08 Billion CNY | 4.77% |
| 2023 Q4 | 13.5 Billion CNY | 0.0% |
| 2023 Q3 | 13.5 Billion CNY | 3.27% |
| 2022 Q1 | 12.35 Billion CNY | 6.55% |
| 2022 Q2 | 12.35 Billion CNY | 0.0% |
| 2022 Q3 | 12.48 Billion CNY | 1.07% |
| 2022 Q4 | 12.48 Billion CNY | 0.0% |
| 2022 FY | 12.48 Billion CNY | 7.68% |
| 2021 Q2 | 12.19 Billion CNY | 0.0% |
| 2021 Q4 | 11.59 Billion CNY | 0.0% |
| 2021 Q1 | 12.19 Billion CNY | 11.46% |
| 2021 FY | 11.59 Billion CNY | 5.97% |
| 2021 Q3 | 11.59 Billion CNY | -4.93% |
| 2020 FY | 10.94 Billion CNY | 4.5% |
| 2020 Q1 | 11.26 Billion CNY | 7.64% |
| 2020 Q2 | 11.26 Billion CNY | 0.0% |
| 2020 Q3 | 10.94 Billion CNY | -2.92% |
| 2020 Q4 | 10.94 Billion CNY | 0.0% |
| 2019 Q3 | 10.46 Billion CNY | 2.39% |
| 2019 Q1 | 10.22 Billion CNY | 4.67% |
| 2019 Q2 | 10.22 Billion CNY | 0.0% |
| 2019 Q4 | 10.46 Billion CNY | 0.0% |
| 2019 FY | 10.46 Billion CNY | 7.17% |
| 2018 Q1 | 9.58 Billion CNY | 7.98% |
| 2018 Q4 | 9.76 Billion CNY | 0.0% |
| 2018 FY | 9.76 Billion CNY | 10.07% |
| 2018 Q2 | 9.58 Billion CNY | 0.0% |
| 2018 Q3 | 9.76 Billion CNY | 1.94% |
| 2017 Q2 | 8.93 Billion CNY | 0.0% |
| 2017 Q4 | 8.87 Billion CNY | 0.0% |
| 2017 FY | 8.87 Billion CNY | 8.45% |
| 2017 Q3 | 8.87 Billion CNY | -0.64% |
| 2017 Q1 | 8.93 Billion CNY | 9.15% |
| 2016 Q1 | 7.05 Billion CNY | 14.11% |
| 2016 Q2 | 7.05 Billion CNY | 0.0% |
| 2016 Q3 | 8.18 Billion CNY | 16.02% |
| 2016 Q4 | 8.18 Billion CNY | 0.0% |
| 2016 FY | 8.18 Billion CNY | 32.38% |
| 2015 FY | 6.18 Billion CNY | 11.75% |
| 2015 Q1 | 6.17 Billion CNY | 11.59% |
| 2015 Q2 | 6.17 Billion CNY | 0.0% |
| 2015 Q3 | 6.2 Billion CNY | 0.49% |
| 2015 Q4 | 6.18 Billion CNY | -0.34% |
| 2014 Q3 | 5.53 Billion CNY | -3.02% |
| 2014 Q1 | 5.7 Billion CNY | 10.81% |
| 2014 Q4 | 5.53 Billion CNY | 0.0% |
| 2014 FY | 5.53 Billion CNY | 7.46% |
| 2014 Q2 | 5.7 Billion CNY | 0.0% |
| 2013 Q4 | 5.14 Billion CNY | 0.0% |
| 2013 FY | 5.14 Billion CNY | 62.46% |
| 2013 Q3 | 5.14 Billion CNY | 25.2% |
| 2013 Q2 | 4.11 Billion CNY | 0.0% |
| 2013 Q1 | 4.11 Billion CNY | 29.76% |
| 2012 FY | 3.16 Billion CNY | 12.46% |
| 2012 Q2 | 3.15 Billion CNY | 0.0% |
| 2012 Q4 | 3.16 Billion CNY | 0.0% |
| 2011 Q4 | 2.81 Billion CNY | 0.0% |
| 2011 FY | 2.81 Billion CNY | 29.55% |
| 2011 Q2 | 2.51 Billion CNY | 0.0% |
| 2010 Q2 | 2.08 Billion CNY | 0.0% |
| 2010 Q4 | 2.17 Billion CNY | 0.0% |
| 2010 FY | 2.17 Billion CNY | 15.15% |
| 2009 Q4 | 1.88 Billion CNY | 0.0% |
| 2009 FY | 1.88 Billion CNY | 5.23% |
| 2008 FY | 1.79 Billion CNY | 2.72% |
| 2007 FY | 1.74 Billion CNY | 16.5% |
| 2006 FY | 1.5 Billion CNY | 3.45% |
| 2005 FY | 1.45 Billion CNY | 15.42% |
| 2004 FY | 1.25 Billion CNY | 39.82% |
| 2003 FY | 898.51 Million CNY | 13.4% |
| 2002 FY | 792.32 Million CNY | 28.24% |
| 2001 FY | 617.86 Million CNY | 19.37% |
| 2000 FY | 517.6 Million CNY | 131.66% |
| 1999 FY | 223.42 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AstraZeneca PLC | 100.97 Billion USD | 86.623% |
| Bristol-Myers Squibb Company PFD CONV 2 | 95.15 Billion USD | 85.805% |
| CSPC Pharmaceutical Group Limited | 6.52 Billion USD | -107.046% |
| Clarus Therapeutics Holdings, Inc. | 51.7 Million USD | -26023.118% |
| Novartis AG | 99.94 Billion USD | 86.485% |
| PT Kalbe Farma Tbk. | 1.75 Billion USD | -668.034% |